The fourth individual (PIVUS 931) was positive for JAK2 V617F as well as a TP53 mutation; he was subsequently diagnosed with polycythemia vera following recruitment into the PIVUS study. The gene discussed is JAK2; the disease is acquired polycythemia vera.